Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Stendörren Fastigheter in connection with its listing on Nasdaq Stockholm
Mandate

Vinge advises Stendörren Fastigheter in connection with its listing on Nasdaq Stockholm

March 30, 2018

Vinge advises Stendörren Fastigheter AB (publ) in connection with its list change from Nasdaq First North Premier to Nasdaq Stockholm’s main market.

The prospectus was published on 29 March 2018 and the trading on Nasdaq Stockholm is expected to commence on 10 April 2018.

Stendörren is a property company that owns, develops and manages properties within the Greater Stockholm and Mälardalen area, with a primary focus on properties within the logistics, warehouses and lighter industry segments. Stendörren’s property portfolio consists of 101 properties with an underlying value of approximately 6.6 billion SEK.

Vinge’s team has primarily consisted of Jesper Schönbeck, David Andersson, Nils Fredrik Dehlin, William Kåge, Frida Ställborn, Sara Osman and Hampus Olsson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026